Loading clinical trials...
Loading clinical trials...
This research is being done to find out if pemetrexed and cisplatin work better when given together with an experimental drug called MORAb-009 in patients with malignant pleural mesothelioma.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Morphotek
NCT00242723 · Malignant Pleural Mesotheliomas NOS, Esophageal Cancers NOS, and more
NCT07510815 · Malignant Pleural Mesotheliomas
NCT06037941 · Malignant Pleural Mesothelioma
NCT05765084 · Malignant Pleural Mesothelioma
NCT04577326 · Malignant Pleural Mesothelioma (MPM)
University of Alabama, Birmingham
Birmingham, Alabama
University of California, San Diego
La Jolla, California
UCLA Medical Hematology & Oncology
Los Angeles, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions